Denmark-based preclinical CRO, Scantox, together with its majority owner Impilo, has acquired Gentronix, a UK based GLP compliant genetic toxicology CRO. Gentronix is recognized for its high-quality genetic toxicology services…
UK: Scantox fills gap in portfolio with acquisition of Gentronix
…
…






